Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Zealand Pharma Ord Shs ZLDPF

Healthcare Biotechnology

Zealand Pharma A/S is a Denmark-based biotechnology company. The Company is focused on the discovery, design and development of peptide-based medicines for metabolic and gastrointestinal diseases and other rare disease areas with unmet medical needs. The Company's peptide-based product candidates includes clinical development, registration and, potentially, commercialization. Its pipeline... see more

Add To Watchlist

Recent & Breaking News (PINL:ZLDPF)

Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021

GlobeNewswire August 5, 2021

Zealand Pharma A/S - Final Transactions Under Share Repurchase Program

GlobeNewswire July 27, 2021

Zealand Pharma A/S - Transaction Under Share Repurchase Program

GlobeNewswire July 20, 2021

Zealand Pharma A/S - Transaction Under Share Repurchase Program

GlobeNewswire July 13, 2021

ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM

GlobeNewswire July 6, 2021

Total number of shares and voting rights in Zealand Pharma at June 30, 2021

GlobeNewswire June 30, 2021

Zealand Pharma to Present Data on Glepaglutide at the 17th Congress of the Intestinal Rehabilitation and Transplantation Association (CIRTA)

GlobeNewswire June 29, 2021

Zealand Pharma A/S - Share Buy-Back Program Under Safe Harbour to Aquire Danish Common Stock for Employee Incentive Programs

GlobeNewswire June 28, 2021

Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE® (dasiglucagon) injection

GlobeNewswire June 24, 2021

Zealand Pharma to Participate in LifeSci Nordic Biotech Summit

GlobeNewswire June 22, 2021

Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions

GlobeNewswire June 16, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire June 11, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire June 10, 2021

Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

GlobeNewswire June 3, 2021

Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH

GlobeNewswire June 2, 2021

Total number of shares and voting rights in Zealand Pharma at May 31, 2021

GlobeNewswire May 31, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire May 28, 2021

Zealand Pharma to participate in Jefferies Virtual Healthcare Conference

GlobeNewswire May 26, 2021

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

GlobeNewswire May 20, 2021

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

GlobeNewswire May 14, 2021